Cyclin D1 and Cancer Development in Laryngeal Premalignancy Patients

In a previous trial, we found that combined 13-cis retinoic acid (13-cRA), interferon-α and α-tocopherol more effectively reversed advanced premalignant lesions of the larynx than of the oral cavity and that cyclin D1 (CD1)G/A870 single nucleotide polymorphism correlated with cancer risk. We conduct...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cancer Prev Res (Phila)
Auteurs principaux: Papadimitrakopoulou, Vassiliki, Izzo, Julie G., Liu, Diane D., Myers, Jeffrey, Ceron, Tania L., Lewin, Jan, William, William N., Atwell, Anthea, Lee, J. Jack, Gillenwater, Ann, El-Naggar, Adel, Wu, Xifeng, Lippman, Scott M., Hittelman, Walter N., Hong, Waun Ki
Format: Artigo
Langue:Inglês
Publié: 2009
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4243520/
https://ncbi.nlm.nih.gov/pubmed/19139013
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1940-6207.CAPR-08-0111
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires